The head of the U.S. Food and Drug Administration (FDA)’s vaccine advisory committee recused herself from the review of vaccines for the novel coronavirus. The move was announced due to the advisor’s role in overseeing a clinical study for Moderna’s mRNA vaccine candidate.
First reported by Reuters, Hana El Sahly, an associate professor of virology and microbiology at Baylor College of Medicine in Houston and the chairwoman of the FDA’s Vaccines and Related Biological Products Advisory Committee, was named one of three lead investigators for Moderna’s late-stage COVID-19 vaccine trial.
